BioSkryb to introduce new products and novel applications of industry-leading portfolio that advance the single-cell multiomics field through simultaneous interrogation of DNA, RNA, and targeted proteins from each cell DURHAM, N.C. – BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete DNA-informed multiomic view of the cellular ecosystem, today announced that it […]
FREMONT, Calif. — Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput sequencing architecture, today announced the launch and full commercial availability of the UG 100™ at the upcoming Advances in Genome Biology and Technology (AGBT) conference on February 5, 2024. The UG 100™ system, Ultima’s first commercial product, leverages a unique sequencing […]
COLOGNE, Germany — Singleron Biotechnologies, a leader in single cell multi-omic solutions for precision medicine, announced two new commercial product launches : AccuraSCOPE® Single Cell Transcriptome and Genome Library Kit and the AccuraSCOPE® Single Cell Full-Length Transcriptome Library Kit. AccuraSCOPE Single Cell Transcriptome and Genome Library Kit opens new possibilities for single cell multi-omic analysis by profiling […]
Collaboration aims to commercialise a Current Good Manufacturing Practice (cGMP) validated test to enable advanced and innovative analysis for multiple critical quality attributes of mRNA products The simplification of analytical testing requirements could accelerate the path to market for mRNA products such as vaccines for infectious diseases Lonza, a global development and manufacturing partner […]
Salvus, LLC seeks partner companies to commercialize technology that enables more timely PFAS management and remediation decisions VALDOSTA, Ga. — Salvus, LLC, a CJB Company, has entered into a licensing agreement with Georgia Tech Research Corporation (GTRC) to gain access to PFAS sensing technology for use in the Salvus™ Detection Platform, the world’s first handheld interferometric detector. Utilizing […]
WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY), today announced that Sophie Vandebroek and Michael Klobuchar have been elected to its board of directors, effective February 1, 2024. “I am pleased to welcome Michael Klobuchar and Sophie Vandebroek to Revvity’s board and look forward to their contributions as we execute on our strategic vision,” said Alexis Michas, […]
Partnership aims to help shape research, education and outreach in microbiomes – the community of microorganisms within an environment QIAGEN to provide instruments and solutions for shared research and education facility at the Huck Institutes’ “One Health Microbiome Center” to support faculty and students Facility at the prominent U.S. university to provide a site for […]
Partnership aims to help shape research, education and outreach in microbiomes – the community of microorganisms within an environment QIAGEN to provide instruments and solutions for shared research and education facility at the Huck Institutes’ “One Health Microbiome Center” to support faculty and students Facility at the prominent U.S. university to provide a site for […]
The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing capabilities Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Bioma4me, a Brazil-based company focused on genetic sequencing to drive precision medicine to the Brazilian […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of Twist Express Genes, a new leading gene synthesis service with an order to shipping turnaround starting at five business days1, to include larger DNA preparations […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
